Oral arguments held on case involving nine patents held by biotech firm.
Myriad Genetics isolated two types of material linked to hereditary risk for two cancers.
Conventional patents are held as the exclusive intellectual property of the inventor.
Question is whether products of nature should be treated similarly under the law.
